This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bruker Cellular Analysis, Inc. for the provision of consumable lab supplies, specifically Optoselect 11k and 20k chips. The contract, valued at $14,654.00, will run through October 31, 2024. Bruker Cellular Analysis, Inc. is a small disadvantaged business that manufactures the optofluidic platforms and related...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded a $14,654 firm fixed price purchase order contract to Bruker Cellular Analysis, Inc. for the delivery of OPTOSELECT CHIPS. Bruker Cellular Analysis is a small disadvantaged business that manufactures optofluidic platforms and related consumables for single cell analysis. This award supports NIAID's efforts to combat the COVID-19 pandemic, with the chips being...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business and manufacturer of goods, for an optofluidic platform and related consumables. The $219,426.90 contract is to provide an essential service agreement for the NIAID Beacon Optofluidic System, which is utilized by the NIAID's Laboratory...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, awarded a $114,750.00 firm fixed-price purchase order contract to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business manufacturer located in Emeryville, California. The contract, titled "BEACON ESSENTIAL SERVICE PLAN," has a completion date of June 29, 2026. The contract does not have a set-aside designation. Bruker Cellular Analysis, Inc....
This is a $34,400.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business manufacturer of goods. The contract is for an ISOSPARK DUO SERVICE AGREEMENT and does not have a set-aside designation. The contract supports Bruker's provision of advanced laboratory equipment, consumables, and services, with a focus on supporting COVID-19 related research and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $109,725.00 firm fixed price purchase order contract to Bruker Cellular Analysis, Inc. for the BEACON ESSENTIAL SERVICE PLAN. Bruker Cellular Analysis, Inc. is a small disadvantaged business that manufactures optofluidic platforms and consumables for single cell analysis. This award, which has a completion date of June 29, 2025, is likely part of...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bruker Cellular Analysis, Inc., a small disadvantaged business manufacturer, for consumables compatible with the Beacon Optofluidic System. The contract has a total ceiling value of $88,292.85 and a period of performance ending on July 30, 2023. The contract was awarded on August 30, 2022 on an other than...
This federal contract award to Bruker Cellular Analysis, Inc. for $331,949.00 was issued by the Department of Health and Human Services' National Institutes of Health, specifically the National Institute of Allergy and Infectious Diseases. The contract is for the provision of an optofluidic platform and related consumables to enable single cell analysis, which is being utilized for antibody discovery and development against SARS-CoV-2 in response to the COVID-19 pandemic. The contract is a...
Bruker Cellular Analysis, Inc. was awarded a $367,763 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide optofluidic platform consumables for antibody discovery in support of COVID-19 response efforts. As part of its mission to accelerate and expand biomedical research on infectious diseases, the NIH-NIAID is utilizing Bruker's single-cell analysis technology and consumables to facilitate rapid antibody...
This is a $14,228 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Bruker Spatial Biology, Inc., a for-profit manufacturer of scientific instruments and reagents. The contract is for the procurement of NanoString panel and reagent kits, which are critical tools for medical and scientific research conducted by federal agencies. The contract has an ultimate completion date of August 31, 2025 and was awarded on April 24, 2025. Bruker...